NEWS: Curebase closes $40M Series B with strategic investment by Gilead. Read about it in TechCrunch, Fierce Biotech, andEndpoints News.

Welcome to the Curebase Resource Center

This is where you'll find all the educational resources you need to learn about our work and mission.

White papers and case studies

Guide

Guide to clinical sites in DCTs

Learn about the relationship between decentralized clinical trial vendors, sponsors, and virtual, traditional, and hybrid trial sites in the design phase of clinical studies.

white paper

Learn how Curebase is bringing infectious disease studies to patients

Curebase infectious disease trials successfully enroll patients utilizing a new kind of model that meets patients where they are through community healthcare and virtual settings.

white paper

The Ultimate Guide for Selecting a Full-Service DCT Vendor

This comprehensive guide takes you step-by-step through the process of selecting the best full-service decentralized clinical trial (DCT) vendor for your study.

white papers

Learn how metaMe health achieved FDA clearance through Curebase’s end-to-end capabilities

Read about how Curebase employed highly sophisticated decentralized methods in this pivotal trial with a combination of software, virtual site operations, and operations staff support.

white paper

A guide to navigating CNS clinical trials

This comprehensive guide to designing and executing Central Nervous System (CNS) clinical trials touches on common challenges. Learn how DCT tools and best practices from industry standards and FDA recommendations can be used to overcome these issues.

Case Study

How a Lyme diagnostic study reached patients across 300+ zip codes in endemic regions

This study had few in-person components such as blood sample collections, and the sponsor was primarily focused on recruiting symptomatic patients within a short window of time.

Case Study

How a Cofactor oncology diagnostic study experienced 76% patient retention

This ongoing study needed to collect tumor biopsy samples in oncology clinics where qualified patients were likely to be.

Case Study

How flexible site models allow diagnostic studies to more effectively reach patients

Learn how Checkable Medical experienced a 2-4 week activation period using flexible site models.

Case Study

Curebase fast tracks recruitment by activating community clinics to enroll patients in Clip Health chlamydia diagnostic study

In 2019, Clip Health was looking to study the accuracy and effectiveness of their SheCares self-administered diagnostic test for Chlamydia. Clip Health’s product vision was to offer healthcare solutions with rapid, accurate, decentralized diagnostics at the core.

Case study

Curebase optimizes patient retention rates in CNS studies by implementing validated engagement tactics

In Curebase’s first international study, Quit Genius, an addiction digital clinic based in the United Kingdom was looking to test the preliminary effectiveness of a novel digital therapeutic intervention for smoking cessation.

Case Study

Expanding patient access with virtual site model and digital recruitment in cancer mental health DTx study

Blue Note Therapeutics was looking to recruit close to 400 patients in a fully-remote randomized controlled trial.

Case Study

How a Lyme diagnostic study reached patients across 300+ zip codes in endemic regions

This study had few in-person components, and the sponsor was primarily focused on recruiting symptomatic patients within a short window of time.

Case Study

How a Cofactor oncology diagnostic study experienced 76% patient retention

This ongoing study needed to collect tumor biopsy samples in oncology clinics where qualified patients were likely to be.

Case Study

How flexible site models allow diagnostic studies to more effectively reach patients

Learn how Checkable Medical experienced a 2-4 week activation period using flexible site models.

Case Study

Curebase fast tracks recruitment by activating community clinics to enroll patients in Clip Health study

In 2019, Clip Health was looking to study the accuracy and effectiveness of their SheCares self-administered diagnostic test for Chlamydia. Their vision was to offer healthcare solutions with rapid, accurate, decentralized diagnostics at the core.

Case Study

Curebase optimizes patient retention rates in CNS studies by implementing validated engagement tactics

In Curebase’s first international study, Quit Genius, an addiction digital clinic based in the United Kingdom was looking to test the preliminary effectiveness of a novel digital therapeutic intervention for smoking cessation.

Blog

Get the inside story

Blog

Addressing long-term follow-up data collection
March 24, 2023

How DCT technology can address data capture challenges in LTFU studies

Blog

Phase IV trials vs. Long-term follow-up trials
March 16, 2023

The differences and similarities between long-term follow-up and phase IV trials

Blog

benefits of DCTs for oncology LTFU studies
March 9, 2023

Leveraging DCT technology, services, and site models for long-term follow-up oncology studies

Webinars

Learn from the experts

Webinar

March 1, 2023

Conducting Quality-Driven Trials for Digital Therapeutics

Webinar

December 12, 2022

Standards and Methodologies in DCTs: What's New and What's Not?

Webinar

December 12, 2022

How to maximize efficiency when staffing decentralized clinical trials

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Subscribe to Curebase content

Get our most recent blogs, whitepapers, webinars and case studies delivered straight to your inbox.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
335 S Van Ness Ave, San Francisco, CA,
94103-3627, United States